Clopidogrel Medreg 75 mg filmom obalené tablety

DRUG2 trials

Sponsors

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Casa Di Cura Accreditata Istituto Chirurgico Ortopedico Traumatologico Marco Pasquali

Conditions

Cardiovascular diseaseDiabetes MellitusObesity (BMI≥30kg/m2)Overweight (BMI ≥27 kg/m²)Patients with coronary artery disease and an indication for PCI

Phase 3

Impact of Oral Semaglutide on Platelet Reactivity in Patients with Diabetes Mellitus or Overweight with High Risk or established Cardiovascular Disease: the SEMA-PLAT Study

Not yet recruitingCTIS2025-522486-29-01

Casa Di Cura Accreditata Istituto Chirurgico Ortopedico Traumatologico Marco PasqualiCardiovascular disease, Diabetes Mellitus, Obesity (BMI≥30kg/m2) +1

Target: 212Updated: 2026-04-23

Phase 4

COATS (genetic Clopidogrel response testing to finetune the antithrombotic regimen in (D)OAC Treated patients undergoing PCI) Study

Not yet recruitingCTIS2024-512350-17-01

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Patients with coronary artery disease and an indication for PCI

Target: 520Updated: 2024-09-13